Prevalência de infecção em unidades de terapia intensiva de um hospital escola terciário by Toufen Junior, Carlos et al.
254
REV. HOSP. CLÍN. FAC. MED. S. PAULO 58(5):254-259, 2003
From the Division of Respiratory Diseases,
Heart Institute (INCOR), Hospital das
Clínicas, Faculty of Medicine, University of
São Paulo – São Paulo/SP, Brazil.
Received for publication on
March 17, 2003.
PREVALENCE RATES OF INFECTION IN INTENSIVE
CARE UNITS OF A TERTIARY TEACHING HOSPITAL
Carlos Toufen Junior, André Luiz Dresler Hovnanian, Suelene Aires Franca and
Carlos Roberto Ribeiro Carvalho
TOUFEN Jr. C et al. - Prevalence rates of infection in intensive care units of a tertiary teaching hospital. Rev. Hosp. Clín. Fac.
Med. S. Paulo 58 (5):254-259, 2003.
OBJECTIVE: To determine the prevalence rates of infections among intensive care unit patients, the predominant
infecting organisms, and their resistance patterns. To identify the related factors for intensive care unit-acquired infection
and mortality rates.
DESIGN: A 1-day point-prevalence study.
SETTING: A total of 19 intensive care units at the Hospital das Clínicas - University of São Paulo, School of Medicine
(HC-FMUSP), a teaching and tertiary hospital, were eligible to participate in the study.
PATIENTS: All patients over 16 years old occupying an intensive care unit bed over a 24-hour period. The 19
intensive care unit s provided 126 patient case reports.
MAIN OUTCOME MEASURES: Rates of infection, antimicrobial use, microbiological isolates resistance patterns,
potential related factors for intensive care unit-acquired infection, and death rates.
RESULTS: A total of 126 patients were studied. Eighty-seven patients (69%) received antimicrobials on the day of
study, 72 (57%) for treatment, and 15 (12%) for prophylaxis. Community-acquired infection occurred in 15 patients (20.8%),
non- intensive care unit nosocomial infection in 24 (33.3%), and intensive care unit-acquired infection in 22 patients
(30.6%). Eleven patients (15.3%) had no defined type. The most frequently reported infections were respiratory (58.5%).
The most frequently isolated bacteria were Enterobacteriaceae (33.8%), Pseudomonas aeruginosa (26.4%), and
Staphylococcus aureus (16.9%; [100% resistant to methicillin]). Multivariate regression analysis revealed 3 risk factors for
intensive care unit-acquired infection: age ≥ 60 years (p = 0.007), use of a nasogastric tube (p = 0.017), and postoperative
status (p = 0.017). At the end of 4 weeks, overall mortality was 28.8%. Patients with infection had a mortality rate of 34.7%.
There was no difference between mortality rates for infected and noninfected patients (p=0.088).
CONCLUSION: The rate of nosocomial infection is high in intensive care unit patients, especially for respiratory
infections. The predominant bacteria were Enterobacteriaceae, Pseudomonas aeruginosa, and Staphylococcus aureus
(resistant organisms). Factors such as nasogastric intubation, postoperative status, and age ³60 years were significantly
associated with infection. This study documents the clinical impression that prevalence rates of intensive care unit-acquired
infections are high and suggests that preventive measures are important for reducing the occurrence of infection in critically
ill patients.
DESCRIPTORS: Intensive care unit. Nosocomial infection. Prevalence rate.
Intensive care units (ICUs) are of
paramount importance in the control
and treatment of the most variable and
severe illnesses that affect the human
body. They represent a powerful tool
in modern medicine.
In the beginning, beds for intensive
care were established to provide post-
operative care for critical patients in
1920s. During the Second World War,
they became more prevalent. The first
ICUs were created in the 1950s to treat
patients who needed special monitor-
ing during the postoperative period of
cardiac surgery. In 1971, the Society
of Critical Care Medicine was
founded, and during this decade, inten-
sive care medicine reached the posi-
tion of a medical specialty.
In spite of their invaluable and
well-established role, ICUs bring some
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degree of morbidity to patients, and
nosocomial infection is clearly related
to that.
Nosocomial infection is associated
with a considerable increase in morbid-
ity and mortality of patients at a hos-
pital as well as to significant increases
in costs1. Nosocomial infections occur
in 5% to 17% of hospitalized pa-
tients1. In ICUs, where the frequent use
of invasive procedures and multiple
therapies expose patients to an in-
creased risk, prevalence rates are even
higher1.
Data from the Study on the Effi-
cacy of Nosocomial Infection Control
(SENIC) show that one-third of noso-
comial infections could be prevented
through infection control and vigi-
lance programs2.
In view of the relevance and impact
of such observations, it is crucial to
know the prevalence rates and nature
of nosocomial infections to achieve
satisfactory results in controlling this
important phenomenon.
The present study was undertaken
to determine the prevalence rates of
infection for ICU patients in our hos-
pital, identify the most common infec-
tious agents and their resistance pat-
terns, and establish the prevalence rates
of ICU-acquired infection and the pos-
sible associated factors.
PATIENTS  AND  METHODS
Setting. A total of 19 ICUs at a
teaching and tertiary hospital were eli-
gible to participate in the study.
Pediatric intensive care and infant spe-
cial care units were excluded from the
study. The study period lasted 24
hours during June 15, 2000. Seventeen
volunteers (medical doctors and stu-
dents of medicine) participated in the
experiment collecting data on a survey
record form.
Patients. All patients over 16 years
of age occupying a bed in a participat-
ing ICU over the study period took
part in the study. For each patient, in-
formation was collected concerning
demographics (age and gender), opera-
tive and clinical status on admission
to the ICU, and diagnostic and thera-
peutic interventions performed on the
study day. The Simplified Acute
Physiologic Score II (SAPS II)3 was cal-
culated from data collected in the first
24 hours of ICU admission.
Types of infection. The presence or
absence of infection by type was docu-
mented according to the standard defi-
nitions of the Centers for Disease Con-
trol and Prevention (CDC):
• Community-acquired – an infec-
tion occurring in the community
and manifested on admission to
hospital;
• Hospital-acquired – an infection
manifested on admission to the
ICU and deemed to be related to
the present hospital admission;
• ICU-acquired – an infection hav-
ing originated in the ICU and ac-
tive or under treatment on the day
of study but not clinically mani-
fested at the time of admission to
the ICU.
Antimicrobials prescribed on June
15, whether for treatment or prophy-
laxis, were documented. Microbiologi-
cal data were recorded whenever avail-
able, including the results of bacterio-
logic sampling undertaken on or be-
fore the day of study.
Recorded risk factors for ICU-ac-
quired infection included the presence
or absence of intravascular and urinary
catheters, nasogastric intubation, me-
chanical ventilation, and agents for
stress ulcer prophylaxis.
Patient outcome was recorded by
researching patient data 4 weeks after
the study day.
Following the completion of the
study, all record forms were collected
centrally. Data entry was followed by
a series of computer validation tests to
detect omissions or inconsistent en-
tries. Any errors identified at this stage
were corrected whenever possible or
the data were recorded as “missing”.
Variables. Some potential risk fac-
tors for ICU-acquired infection were
analyzed. These included: age equal
to or greater than 60 years; kind of ad-
mission (medical or surgical); time pe-
riod of ICU stay; and use of a central
venous catheter, nasogastric tube, uri-
nary catheter, and/or gastric protectors.
Definition of infection. A patient
was given a diagnosis of infection
when there was a medical diagnosis of
an infectious focus that required the
use of antimicrobial treatment.
Cultures. The cultures employed
were: cultures of blood (more than 2
positive pairs of culture for the same
pathogen), urine (more than 10,000
CFU when collected from urinary cath-
eter and 100,000 CFU when not),
broncho-alveolar lavage (more than
10,000 CFU for a single pathogen),
and surgical wounds.
Statistical analysis. The point
prevalence of community-acquired,
hospital-acquired, and ICU-acquired
infections was estimated. Data from the
overall population were used for
analysis of infection. The risk factors
for ICU-acquired infection were esti-
mated at first with a simple unadjusted
analysis. Aiming at adjusting the vari-
ables and controlling the effect of po-
tentially confounding variables, a
multivariate model construction by lo-
gistic regression analysis was per-
formed. Epi Info, version 6.04, and
SPSS, version 6.0.1, were used.
RESULTS
ICU Profiles. Among the 19 ICUs,
with 170 beds, 1 did not participate in
the study because there were no pa-
tients on the day of study. In the re-
maining 18, there were 126 patients.
Patients’ Demographics and Inter-
ventions. Among the 126 patients
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studied, 70 were male (56%); the av-
erage age was 56.6 + 18.1 (SD) years.
Female patients accounted for 44% of
all patients; the average age was 59.2
+ 17.2 (SD) years.
A total of 52 patients had under-
gone surgery 24 hours before admis-
sion, of whom 38 (73%) had elective
and 14 (27%) had emergency surgery.
On the day of the study, 52 patients
(41.3%) were being mechanically ven-
tilated, 86 (68.2%) had a central ve-
nous catheter, 10 (7.9%) had a Swan-
Ganz catheter, 88 (69.8%) had a uri-
nary catheter, and 66 (52.3%) had a
nasogastric tube (Figure 1).
Antimicrobial Use. A total of 87
patients (69%) received antimicrobials
on the day of the study, 72 (82.8%) for
treatment and 15 (17.2%) for prophy-
laxis. The most frequently used antimi-
crobials were cephalosporins (48.6%),
followed by vancomycin (45.8%) and
carbapenems (25%).
Prevalence of infection. Among the
72 patients who received therapeutic
antibiotics, 15 (20.8%) had commu-
nity-acquired infection, 24 (33.3%)
had acquired an infection at another
hospital service before being trans-
ferred to the ICU, 22 (30.6%) had ICU-
acquired infection, and 11 (15.3%)
had no defined type (Figure 2).
Regarding the site of infection, 41
(56.9%) were pulmonary, 5 (7.0%)
were clinical sepsis, and 4 (5.6%) had
an infection site in the urinary tract
(Figure 3).
Overall, 37 (51.4%) of the clini-
cally identified infections were sup-
ported by positive cultures. Fourteen
patients had a mismatch between the
antimicrobial used and the antibio-
gram, representing 19.4% of the 72 pa-
tients that were considered to be clini-
cally infected. This inadequate antimi-
crobial treatment of infection was ob-
served more frequently among patients
with ICU-acquired infection (22.7%),
followed by patients with community-
acquired infection (20.0%), and ac-
quired infection at another hospital
service before being transferred to ICU
(16.6%).
The most frequently reported iso-
lates were as follows: Enterobacte-
riaceae (33.8%), Pseudomonas
aeruginosa (26.4%), Staphylococcus
aureus (16.9%), Streptococci (7.5%),
coagulase-negative staphylococci
(5.6%), and Candida species (7.5%).
Patterns of Antimicrobial Resist-
ance. Among the 9 S. aureus isolates,
all were methicillin-resistant strains
(MRSAs), and all were sensitive to
UC- Urinary Catheter; CVC- Central Venous Catheter; NGT- Nasogastric Tube; MV-
Mechanical Ventilation; SGC- Swan-Ganz Catheter.
Figure 1 - Invasive procedures of 126 patients studied on June 15, 2000.
Figure 2 - Prevalence rates of infection by type of 72 patients who received therapeutic
antibiotics on June 15, 2000.
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vancomycin. Among the 14 cultures
positive for P. aeruginosa, 12 were
tested for gentamicin, with 50% resist-
ance; 10 for imipenem, with 30% re-
sistance; 11 for ceftazidime, with 50%
resistance; 12 for ciprofloxacin, with
41.6% resistance; and 12 for amikacin,
with 41.6% resistance.
Risk Factors for ICU-Acquired In-
fection. Univariate analysis was first
employed to identify possible risk fac-
tors for acquiring infection inside the
ICU environment. Only age equal to or
greater than 60 years was identified as
a risk factor. After stepwise logistic re-
gression analysis to control for the ef-
fects of confounding variables, 3 fac-
tors were independent risk factors: use
of a nasogastric tube (p = 0.017), post-
operative status (p = 0.017,) and age
equal to or greater than 60 years (p =
0.007) (Table 1).
Mortality. At the end of 4 weeks,
overall mortality was 28.8%. Patients
with infection had a mortality rate of
34.7%. Using a chi-square analysis, we
found no difference between mortality
rates for infected and noninfected pa-
tients (p = 0.088).
DISCUSSION
The present study, through a trans-
versal (1-day point prevalence) analy-
sis, reveals a profile of patient infec-
tions in the ICUs of a tertiary teach-
ing hospital. It aims at characterizing
patients with a focus on the prevalence
rates of infection, sites and types of in-
fection, the most prevalent microorgan-
isms, and the antimicrobial resistance
patterns, as well as at identifying the
risk factors for ICU-acquired infection.
Medical staff that assisted the pa-
tients in the ICUs found 72 (57.1%)
infected; thus, they prescribed antimi-
crobials with therapeutic intention.
Similar results were obtained in a
Mexican study (58.2%)5. The EPIC,
a European study, showed lower rates
of infection (44.8%)1. The great major-
ity of patients (73.8%) received anti-
microbials. This finding shows that
because of the difficulty in establish-
ing the specific diagnosis and because
of the severity of infection, antimicro-
bials are empirically introduced most
of the time. Among this population, 15
(20.8%) had community-acquired in-
fection, 24 (33.3%) had infections that
were hospital-acquired outside the
ICU, and 22 (30.6%) developed infec-
tion inside the ICU. The remainder 11
infected patients (15.3%) were not clas-
sified. Higher prevalence rates for ICU-
acquired infections are reported in the
literature1,5.
Overall, 37 (51.4%) of the clini-
cally identified infections were sup-
ported by positive cultures. These iso-
lates might not necessarily have rep-
resented the cause of the infection.
They might have only reflected possi-
ble contamination of the sample or the
process of colonization. Nevertheless,
regarding the isolates reported, the
predominance of gram-positive cocci,
particularly S. aureus, and gram-nega-
Table 1 - Risk factors for Intensive Care Unit-acquired infection after logistic
regression analysis.
Variable p value
Medical admission 0.78
Surgical admission† 0.017
Time period of Intensive Care Unit stay 0.79
Use of Central Venous Catheter 0.58
Use of Nasogastric Tube† 0.017
Use of Urinary Catheter 0.76
Use of gastric protectors 0.72
Age ≥ 60 years† 0.007
SAPS II 0.87
†
 Independent risk factors.
Figure 3 - Prevalence rates of infection by site of 72 patients who received therapeutic antibiotics
on June 15, 2000.
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tive organisms, especially P.
aeruginosa, are in accordance with
findings of recent studies1,5. Fourteen
(11.1%) of the patients received inad-
equate treatment on the day of the
study. This represents 19.4% of the 72
patients that were considered to be
clinically infected. This finding could
be explained by 2 possibilities: mis-
taken diagnosis by the medical team
or failure of the diagnostic method if
the medical diagnosis was correct.
Inadequate antimicrobial treatment
of infection was observed more fre-
quently among patients with ICU-ac-
quired infection (22.7%), followed by
patients with community-acquired in-
fection (20.0%), and acquired infec-
tion at another hospital service before
transfer to the ICU (16.6%).
It is interesting that 56.9% of pa-
tients were being treated for pneumo-
nia, a number considerably higher than
for other infections. This finding re-
veals the concern of medical teams
with pneumonia, maybe because of its
high morbidity and mortality rates and
its known high prevalence rates. Ad-
ditionally, it is quite difficult to dis-
tinguish nosocomial pneumonia from
bacterial tracheobronchial coloniza-
tion using only clinical findings, es-
pecially in intubated patients6. Defini-
tive diagnosis that pneumonia is the
result of a specific pathogen can be
obtained only if cultures of blood,
pleural fluid, or spinal fluid are posi-
tive in the presence of a lung infiltrate
and a compatible clinical picture7.
Bacteremia is uncommon in most
pneumonias, usually occurring in only
8% to 15% of nosocomial pneumo-
nias8,9.
Regarding bacterial agents, the
most prevalent were a member of the
family of Enterobacteriaceae, Pseu-
domonas aeruginosa, and
Staphyloccocus aureus, which were re-
spectively 33.8%, 26.4%, and 16.9%
of the isolated agents. Concerning re-
sistance patterns for S. aureus, 100%
were resistant to methicillin and 100%
had sensitivity to vancomycin. Among
cultures of P. aeruginosa, none re-
vealed sensitivity higher than 70% to
any antimicrobial tested. These data
confirm that in the intensive care
medical environment, the most patho-
genic agents, those that are in general
the most resistant, are the most fre-
quently found1,5. Regarding use of
antimicrobials, the most frequently
used were cephalosporins (35 patients,
48.6%), vancomycin (33, 45.8%),
imipenem (18, 25%), clindamycin (8,
11.1%), and aminoglycosides (6, 8.3%).
Normally, empirical treatment schemes
are based on knowledge of local
microbiota and utilization of a wide
range of antimicrobials associated or
not with others of more specific ac-
tion, such as vancomycin for S. aureus
or clindamycin for anaerobic bacteria.
Three factors were significantly re-
lated to ICU-acquired infection: use of
a nasogastric tube, postoperative sta-
tus, and age equal to or greater than
60 years.
The finding of a relationship be-
tween nasogastric intubation and in-
fection is in accordance with the lit-
erature7,10. According to the literature,
pneumonia was the most frequently
observed infection in ICUs, and naso-
gastric intubation represents one of
the main risk factors. Aspiration of
oropharyngeal contents, which is rich
in bacteria, is facilitated by the pres-
ence of a nasogastric tube, particularly
if food is administered in bolus or
when the patient is in a supine posi-
tion. Use of drugs that increase gastric
pH, thus facilitating growth of gram-
negative bacteria, raises the risk of pul-
monary infections. Our data show that
these drugs were used frequently (107
patients – 85.6% – were given gastric
protectors, while only 6 patients with
a nasogastric tube were not), in ac-
cordance with the relationship pointed
out in the literature7.
Postoperative patients also had a
higher number of infections. This type
of patient has a higher propensity for
developing infectious complications,
since surgical incision represents a
gateway for infection. Additionally,
postoperative patients are intubated
for surgery and have a transitory de-
crease in immune responses due to sur-
gical damage.
Patients of an age equal to or
greater than 60 years have higher rates
of ICU-acquired infections, a finding
that reveals the fragility of the elderly
to infections and invasive procedures.
Our data reveal frequent use of
antimicrobials in our intensive care
medicine environment, even without
laboratory support for it. This finding
has potential implications, in that
treatment with antimicrobials raises
the cost of treatment considerably and
contributes to the selection of multire-
sistant species. The excessive use of
gastric protectors was unexpected,
since there is no evidence that their use
would bring any benefit in terms of re-
duction of digestive complications.
Simple practices could be immediately
performed at ICUs to reduce rates of
pulmonary infections, such as keeping
the head of the bed elevated and tak-
ing care with diet administration.
It should be noted that a preva-
lence study like this one has some
limitations. One limitation concerns
the difficulty in establishing relation-
ships of causality between factors; one
cannot predict which factor comes
first. The other is that 1-day point stud-
ies tend to overestimate long-duration
infections and underestimate the short-
duration ones.
Nevertheless, this type of transver-
sal analysis has fundamental impor-
tance for the knowledge about the
ICU population. It provides an impe-
tus for new strategies and interven-
tions concerning critical patients in
terms of scientific research and clini-
cal practice.
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RESUMO
TOUFEN Jr. C e col. - Prevalência de
infecção em unidades de terapia
intensiva de um hospital escola
terciário. Rev. Hosp. Clín. Fac.
Med. S. Paulo 58 (5):254-259,
2003.
OBJETIVO: Determinar a preva-
lência de infecções em pacientes de
Terapia Intensiva, os agentes infecci-
osos mais comuns e seus padrões de
resistência. Identificar os fatores rela-
cionados a infecção adquirida na Uni-
dade de Terapia Intensiva e as taxas de
mortalidade.
DESENHO: Estudo de prevalência
de um dia.
LOCAL: Um total de 19 Unidades
de Terapia Intensiva do Hospital das
Clínicas da FMUSP (HC-FMUSP) par-
ticiparam do estudo.
PACIENTES: Todos os pacientes
com idade superior a 16 anos interna-
dos em leitos de terapia intensiva por
mais de 24 horas foram incluídos. As
19 Unidades de Terapia Intensiva for-
neceram 126 casos.
VARIÁVEIS: Taxas de infecção,
uso de antibióticos, padrões de resis-
tência microbiológica, fatores relacio-
nados à infecção adquirida na Unida-
de de Terapia Intensiva, taxas de mor-
talidade.
RESULTADOS: Um total de 126
pacientes foi estudado. Oitenta e sete
(69%) receberam antibióticos no dia
do estudo, sendo 72 (57%) para trata-
mento e 15 (12%) para profilaxia. Ba-
seado no tipo, observou-se que a in-
fecção adquirida na comunidade ocor-
reu em 15 pacientes (20,8%), infecção
hospitalar fora da Unidade de Terapia
Intensiva em 24 (33,3%), e infecção
adquirida na Unidade de Terapia In-
tensiva em 22 pacientes (30,6%). Para
11 pacientes (15,3%) não se definiu o
tipo de infecção. Quanto ao sítio de
infecção, as respiratórias foram as in-
fecções mais comuns (58,5%). Os agen-
tes mais freqüentemente isolados fo-
ram: Enterobacteriaceae (33,8%),
Pseudomonas aeruginosa (26,4%) e
Staphylococcus aureus (16,9%; 100%
meticilina-resistentes). Análise multi-
variada identificou 3 fatores associa-
dos à infecção adquirida na Unidade
de Terapia Intensiva: idade maior ou
igual a 60 anos (p=0,007), uso de son-
da nasogástrica (p=0,017) e pós-ope-
ratório (p=0,017). Ao final de quatro
semanas, a taxa de mortalidade foi de
28,8%. Entre os infectados, a mortali-
dade foi de 34,7%. Não houve diferen-
ça entre as taxas de mortalidade para
pacientes infectados e não-infectados
(p=0,088).
CONCLUSÃO: A taxa de infecção
é alta entre os pacientes de terapia in-
tensiva, especialmente as infecções
respiratórias. As bactérias predominan-
tes foram: Enterobacteriaceae. Pseu-
domonas aeruginosa e Staphylo-
coccus aureus (agentes resistentes).
Fatores como uso de sonda nasogás-
trica, pós-operatório e idade maior ou
igual a 60 anos mostraram associação
com infecção. Este estudo documenta
a impressão clínica de que a preva-
lência de infecção adquirida na Uni-
dade de Terapia Intensiva é alta e su-
gere que medidas preventivas são im-
portantes para reduzir a ocorrência
de infecção em pacientes críticos.
DESCRITORES: Unidade de tera-
pia intensiva. Infecção nosocomial.
Taxa de prevalência.
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